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Executive Summary

For the average patient, medical professionals typically recommend exercise to enhance
the health of their patients in multiple ways. Oncology patients, however, often have different
issues that the treating physicians are more concerned about, so physical activity gets placed on
the back burner. The need for exercise in oncology patients is certainly a decision that should be
part of an individualized treatment plan, but it is reasonable to believe that most of these patients
will benefit from participating in an exercise program. With the high demanding need to
decrease chemotherapy side effects and improve lives of those undergoing it, this benchmark
project will review supporting literature evidence that demonstrates a simple intervention to
successfully make that improvement. The PICOT question to be discussed in this paper is: In
oncology patients (P), how does a regular exercise program (I) compared to no exercise program
(C) affect cancer-related fatigue (O) during the first three months of treatment (T)?
1. Rationale
Cancer-related fatigue (CRF) has become well-known as one of the most common
distressing symptoms experienced by oncology patients, as the ongoing physical and emotional
exhaustion can limit one’s ability to function and his or her quality of life (NCCN, 2018). This
clinical issue has a significant role in healthcare due to the high prevalence rate of 50-90% in
patients with a cancer diagnosis (Becze, 2019). CRF remains underdiagnosed and underreported
by patients that believe it is simply a part of the diagnosis and treatment process, thus preventing
the treating providers from managing this symptom. A change is warranted in nursing practice
regarding the desperate need for knowledge on how to best manage and control the effects of
CRF. According to Fernandez et al. (2015), the benefits of exercise not only greatly reduce CRF
and improve quality of life, but also extend to domains of reducing pain, increasing physical
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performance, and improving mental health symptoms. This debilitating symptom can be
managed by the simple action of incorporating exercise into the patient’s daily routine.
Without implementing this evidence-based change, maximum benefits of pharmacologic
treatment may not be reached, the patient’s healthcare costs will likely increase, and more
symptom related hospitalizations can be expected to occur. Haas et al. (2016) explains that
exercise is the sole treatment that provides a broad spectrum of benefit in cancer prevention and
treatment with minimal side effects at the lowest cost. With consistent exercise as a concurrent
treatment, chemotherapy delivery to tumors is increased, healthcare costs including oxygen,
provider visits, and hospitalizations were decreased, and survival rates increased by
approximately 50% (Haas et al., 2016).
2. Literature Synthesis
The appraised literature for this evidence-based change project includes three level I
meta-analysis and systemic review studies, six level II randomized controlled trials (RCT), and
three level III quasi-experimental studies. They all relevantly answer the proposed clinical
question being discussed. According to the evidence, an individualized exercise program should
be considered an effective treatment for CRF reduction in oncology patients; therefore, it should
be incorporated into the standard treatment plans and protocol.
According to the research, exercise not only decreases CRF, but it also reduces
depression and anxiety, increases physical performance, and improves quality of life (Mijwel et
al., 2019; Oertle et al., 2016; Rogers et al., 2017). With the symptoms better controlled by
performing routine physical activity, the patient is more prone to have an increased independence
and ability to perform activities of daily living with less assistance. When the patient has a
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higher level of energy and a more positive mindset, she is more likely to be successful at
completing the cancer treatments and promoting her own self-care at home.
Long term effects of an exercise program were studied by Mijwel et al. (2019) and
Witlox et al. (2018) at one- and four-years post treatment, respectively. It was found that
compared to patients that were not physically active, those that participated in moderate or
vigorous exercise during treatment continued to experience significantly lower CRF at their
long-term follow up appointments (Mijwel et al., 2019; Witlox et al., 2018). These patients also
benefit from generally improved health and reduced financial depletion from prolonged sick
leave (Mijwel et al., 2019).
Findings in two of the meta-analysis studies determined that aerobic exercise, both alone
and in combination with resistance training, had a significant affect in reducing CRF during
chemotherapy treatments, while resistance training alone only moderately improved CRF, and no
physical activity at all had no improvement on symptom management (Meneses-Echávez et al.,
2015; Tian et al., 2016). These finding prove important in the change project to determine the
best type of exercise to incorporate in the program being implemented. The randomized
controlled trial by Patel and Bhise (2017) provided data that demonstrated even patients who
could only tolerate low to moderate intensity exercise experienced a significant reduction in
CRF, better physical performance, and improved quality of life.
Al Maqbali et al. (2019) discusses in the systematic review how multiple studies
discovered that physical activity has the potential to reverse the debilitating symptom of fatigue
in gynecological cancer survivors. This evidence demonstrates the importance of implementing
the exercise as soon as the patient is diagnosed and beginning treatment to prevent from having
to reverse symptoms that have already arose. One RCT deliberated that the higher the intensity
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of exercise early on in the diagnosis, the more improvement will be seen in physical functioning,
quality of life, and CRF (Brown et al., 2018).
An RCT by Kampshoff et al. (2015) and a quasi-experimental study by Marker et al.
(2018) went one step further than testing aerobic exercise on CRF and also investigated the
potential impact of exercise on cardiorespiratory fitness and muscle strength. Both studies
demonstrated that a physical activity intervention significantly improved fatigue,
cardiorespiratory fitness, and muscle strength (Kampshoff et al., 2015; Marker et al., 2018). This
improvement not only increases the quality of life of the patients, but also reduces the need for
medical interventions, such as medications, hospitalizations, or surgeries. Gheyasi et al. (2019)
showed a statistical significance of p <0.001 in the reduction of CRF after just five to ten days of
a cost-effective walking method. All of these studies demonstrate strong evidence to support the
implementation of exercise in oncology patients.
3. Stakeholders
People who are directly and indirectly effected by this intervention are the ones who will
have the biggest impact on the development and success of the overall project. The stakeholders
for this benchmark project include the patient and the patient’s family members or support
system, the oncologist or nurse practitioner provider, the nurses, medical assistants, clinic
director, certified trainer, and the organization management. Each of these project stakeholders
will play a key part in the planning, implementation, evaluation, and dissemination of the
exercise program. The provider will play a key role in assessing the patient, working with the
trainer to develop an individualized plan, and monitoring the progress throughout the program.
The nurses and medical assistants will be the ones collecting essential information and assisting
with basic needs or questions from the patient as well as coordinating a schedule. The clinic
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director and organization management will have an investment role to provide funding and aid in
disseminating the project and developing a policy to include physical activity as part of a
generalized treatment plan for all oncology patients. The patient and family will have the largest
role and impact by participating in all necessary sessions, answering questionnaires honestly, and
providing their feedback regarding their experiences and suggestions.
4. Implementation
To ensure success for any change project, developing a plan is an essential part of the
process. Prior to implementation, it is essential to have an organized approach with preparation
and planning to accomplish a successful vision (Hockenberry et al., 2015). The overall plan for
this program is to take willing participating patients undergoing chemotherapy treatment with a
new diagnosis of cancer and assess them for an individualized and supervised exercise program
in hopes that it will reduce the amount of cancer-related fatigue they experience. After approval
is gained from the administration and clinical director, adult patients will be recruited from
Texas Oncology in Tyler to participate in this change project program. It is intended for twenty
patients to be recruited that will agree to sign an informed consent and participate in twelve
weeks of physical activity.
The major steps of the exercise program implementation plan include obtaining
permission from the clinic administration, gain funding for required equipment and trainer,
obtain equipment needed, build a selectively skilled multidisciplinary team, educate the team on
their assigned roles, recruit patients, provide an education session for the patients regarding the
risks and benefits, assess and individualize plans for the patient, perform a baseline questionnaire
assessment, initiate the exercise program, perform follow up assessments, measure clinical
outcomes, and disseminate results for future programs.
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4.1 Step One
The first step in this project would be to take the proposal to the clinic administration and
discuss with them the idea to ensure that they are interested in allowing it at the facility. A good
idea would be to take a printed and laminated blueprint layout of the timeline and the evaluation
table that demonstrates the research that has been performed over this topic and the statistics that
show the significant advantages of incorporating the exercise program into a practice. Once
granted permission, there would need to be a discussion with the clinical director about funding
of the supplies and trainer. If the clinic director is in agreeance, the funds may be allocated from
the clinic profits and donations collected throughout the year from fundraisers.
4.2 Step Two
Equipment such as a treadmill, resistance bands, and dumbbells will need to be purchased
or donated at this point to prepare for the project implementation. The equipment that is
gathered will be set up in a designated room at the facility. Equipment will be cleaned with
sanitation wipes before and after each patient’s use.
4.3 Step Three
Members of a multidisciplinary team can make or break your project, so selective
involvement is best. Time will need to be spent prior to this point observing coworkers and
employees to choose the strongest people in different areas that are willing to help and have the
skills necessary for success. The team members needed will be the team lead, trainer, clinic
director, provider/nurse practitioner, registered nurse, medical assistant, patient, and the patient’s
support person.
4.4 Step Four
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Once the team has been chosen, specific role education will need to be provided. The
provider role is to assess the patient for eligibility, discuss the importance of physical activity,
review any risks, perform a baseline physical assessment, and address any questions or concerns
from the patient or their support person. The registered nurse role is to review the follow up
assessment questionnaires with the patient at one week, four weeks, and twelve weeks. The
medical assistant will schedule the patient at their convenience for the exercise times and
perform pre and post vital signs to ensure that they are maintaining safe levels to continue. The
clinic director will be responsible for granting permission and allocating funding. The trainer
will be responsible for ensuring patient safety during the sessions and working with the provider
to individualize the program for each patient based on their unique abilities and needs. The team
leader will ensure that all team members have the supplies that are needed, answer questions, and
perform statistical analysis to determine improvement levels based on questionnaires and
physical functioning advancements throughout the program. The patient and support person are
required to come to each scheduled appointment. The patient will participate in stretches,
physical activity deemed appropriate by the provider and trainer, and be responsible for
completing questionnaires honestly.
4.5 Step Five
To recruit patients, each new patient with a cancer diagnosis will be given a brochure and
informed about the program purpose. His or her participation will be optional, and an informed
consent will be reviewed and signed by the patient and provider prior to assessment for initiation.
A goal of twenty patients to participate is made for recruitment purposes.
4.6 Step Six
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During the same week that the patients are recruited and once they have signed the
informed consent, he or she will attend an education session with the provider to learn the
detailed risks and benefits of the program. At this visit, the patient will have a thorough physical
assessment to determine baseline physical functioning. The trainer and provider will collaborate
and determine the individualized exercise plan for the patient based on their unique needs and
abilities, whether it includes stretching, aerobic exercise, weight bearing exercises, resistance
training, or a combination of those. At this educational appointment, the RN will provide a
questionnaire to get a baseline of the patient’s cancer-related fatigue level.
4.7 Step Seven
After all of the above steps have been completed, the next step is to initiate the exercise
program. This program will go for twelve weeks and the patient will meet with the trainer three
times a week on their scheduled dates and times for one hour per day. Appointments will be
made by the medical assistant based on the patient preference and trainer availability.
4.8 Step Eight
After one week, four weeks, and at the completion of the program in twelve weeks, the
RN will administer the questionnaire to monitor changes in the patient’s cancer-related fatigue
levels. The questionnaire will ask questions regarding the patient’s fatigue level each day,
whether the fatigue prevents them from doing any ADLs or IADLs, and how the fatigue has
affected their family and social life. It will also ask about their associated depression, anxiety,
and physical strength capabilities.
4.9 Step Nine
At the completion of the twelve-week exercise program, the outcomes will be measured.
Statistical analysis of the questionnaires with levels of cancer-related fatigue on a scale of 0-100
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will be analyzed to monitor for a significant improvement or note any data changes. The patients
will reflect on any differences in emotional stability of depression and anxiety throughout the
program. Data from the trainer will also be evaluated to observe for increase in physical
functioning and independence of performing ADLs and IADLs.
4.10 Step Ten
Once the statistical data is collected, a debriefing meeting will be held with the project
team to discuss overall benefits and any concerns. This debriefing period will allow discussion
of any actions that were taken with patients throughout the twelve-week program. It will
encourage improvement in future performance and project implementation. Reviewing the topic
that was studied and the results that were evidenced throughout the project is an essential final
step of the teamwork.
4.11 Step Eleven
Finally, the last step in this project is to present the outcomes to the stakeholders and
disseminate the results for future programs. This step will increase awareness of the change
project and research and maximize the impact that it may have in the patients’ health outcomes.
One of the most important steps in any research or change project is making the information
known to a greater amount of people to expand the evidence-based practice in other settings.
5. Timetable / Flowchart
The following flowchart demonstrates the timeline that would have been used this
semester to implement the exercise program project to reduce CRF in oncology patients.
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August 17:
Project proposal
& cost analysis
meeting

August 24-28:
Acquire
equipment
needed

August 31 September 4:
Build project
team & hold
team meeting

September 7-11:
Recruit patients &
patient
education

September 7-11:
Individualize patient
plans & perform
baseline
questionnaire
measurements

September 14:
Initiate program

September 21:
one-week follow
up questionnaire
measurement

October 12:
four-week follow
up questionnaire
measurement

December 7:
12-week final
questionnaire
measurement

December 8:
Measure clinical
outcomes

December 9:
Team debriefing

December 10:
Outcomes
presented &
disseminated

6. Data Collection Methods / Planned Evaluation
Evaluating the outcomes of a change project is an essential part of incorporating it into
evidence-based practice (Brewer & Alexandrov, 2015). For this intervention of an exercise
program to reduce cancer-related fatigue in oncology patients, choosing the best objectives and
outcomes to measure is a major part of portraying if the project is successful or not. The selected
primary outcome for this change project is the level of experienced cancer-related fatigue, while
the secondary outcomes to be evaluated will include costs related to the implementation and
adverse events experienced by the patients during the duration of this twelve-week program.
For the Capstone project this semester, a benchmark project will be completed due to
restrictions placed at most healthcare facilities by COVID-19. In the future, however, the plan is
to implement this project to improve oncology patients’ quality of life. Once the exercise
program is initiated, the next step to consider is how to gain information needed to measure the
outcomes of this intervention. The questionnaires to be completed by the participating patients
are the Piper Fatigue Scale, the Fatigue System Inventory scale, and the Functional Assessment

CANCER-RELATED FATIGUE

15

of Chronic Illness Therapy scale. At each follow up visit, the questionnaire results will be
discussed with the patients to gain a better understanding of their perspective and experiences.
Following completion of the program, the total scores on the surveys for each patient will be
calculated and the increase or decrease in reported fatigue individually will be noted.
Secondary measurable objectives will also be observed during this evaluation, including
costs associated with the project as well as hospitalizations and rehab admissions associated with
fatigue and decreased physical functioning abilities. At the completion of the outcome
measurements, a table will be created with all of the data results gathered and synthesized. This
table will help prepare for an outcome debriefing with management at the facility and
dissemination for future use and incorporation into evidence-based practice.
6.1 Step One
The initial step in this Capstone project evaluation is to decide on the necessary
measurement tools. In this situation, the chosen tools are the Piper Fatigue Scale, the Fatigue
System Inventory scale, and the Functional Assessment of Chronic Illness Therapy scale. These
surveys will determine if the patients experienced any fatigue and to what extent the fatigue
affected their daily lives including their activities of daily living, social lives, work functioning,
and more. According to Tian et al. (2016), the FACT-F scale is the most common measurement
tool for cancer-related fatigue and the revised Piper Fatigue Inventory scale is more consistently
the best validated fatigue measurement instrument. The patients will be asked to complete these
questionnaires at their baseline appointment, at their one week follow up, four week follow up,
and post-completion of the exercise program at the twelve week mark. Having these four
different time points to evaluate will provide better insight on the improvement in the cancerrelated fatigue experienced by these patients.
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6.2 Step Two
The second step of this evaluation process is to discuss the questionnaire results with the
patients. Clarifying survey questions and having a direct one-on-one conversation about their
honest questionnaire answers could provide better insight into adjustments that need to be made
or put into perspective other changes that should be considered to improve their experience and
promote better outcomes. This discussion should take place at each of the follow up visits after
the patient has completed the questionnaires.
6.3 Step Three
The third step in this project proposal outcome measurement is to take the questionnaire
results from each of the four follow up visits and calculate the differences. Each survey will
have a total number associated with the patient’s selected responses. That total number will be
taken at each of the four visits to discover if it is increasing or decreasing, and by how much.
The percentage of increase or decrease will be calculated to distinguish an overall response and
the significance level of the intervention. A 20% decrease or better will signify a significant
improvement in CRF for this project purpose.
6.4 Step Four
After the primary objective of decreasing cancer-related fatigue has been measured, the
evaluation will shift to secondary objectives. In this step, at the project completion follow up
visit, the participating patients will be evaluated and questioned regarding the number of
hospitalizations and rehab admissions occurring during this twelve-week intervention period
related to fatigue or decreased physical functioning. Part of the questionnaires also discuss falls.
If a patient reports a fall on the questionnaire, it will be discussed with them to determine the
number of falls and whether it was related to a lack of strength or fatigue. This may help
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determine to what extent the fatigue is affecting their lives and brainstorm on further ways to
help the patients. If the number of hospitalizations and rehab admissions have decreased, this
will help reinforce the hopeful findings of the change project program.
6.5 Step Five
Another secondary objective to measure will be costs related to the intervention. This
final cost evaluation will occur after the twelve-week program has been completed and all data
can be gathered. The cost analysis will be discussed in the next section designated for that
purpose.
6.6 Step Six
The final step to consider in evaluating the outcomes of this change project is to complete
a table of all the data gathered throughout the program. This table will synthesize the results and
designate whether the patients experienced a significant increase or decrease in their cancerrelated fatigue. After all of the evaluation steps have been completed, a debriefing meeting with
management will occur to review the findings of the project. This synthesis results table will
help prove the necessity of the intervention to improve quality of life in the facility’s patients.
Creating the table for this step will also aid in the dissemination process to incorporate the
exercise program into future evidence-based standard practice.
7. Cost / Benefit Discussion
The cost of this project was analyzed by breaking down the individual expenses of the
certified trainer, the necessary equipment, and hourly wages for staff education. Necessary
equipment for this project is a treadmill, resistance bands, and dumbbells, which averaged out to
be $1500. This cost may be reduced by accepting used and sanitized donations or using profits
from fundraisers often hosted throughout the year. One certified trainer for this implementation
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has an average annual salary of $60,000. Staff education may be provided via web training to be
done virtual over a lunch break to reduce additional hourly wages.
According to an economic burden study performed by Rashid et al. (2016), over 76% of
participating cancer patients receiving chemotherapy experienced a need for outpatient or
inpatient treatment due to adverse events related to their treatment. Twenty-one episodes of
fatigue and muscle-related weakness were reported during their study, which totaled out to
expenses equaling $80,667 (Rashid et al., 2016). This would equal an average of $3,841 for
each patient that is hospitalized or requires treatment for CRF side effects. If twenty
participating patients are each spared one hospitalization episode of side effects related to CRF,
that would save $76,820, which would exceed the expenses necessary for the prevention
program. Due to the escalating costs of clinical trials, the average monthly cost of cancer drugs
has risen to more than $10,000. The positive impact that exercise has during cancer treatments
has led to a reduction in health care costs by significantly reducing ER visits, 30-day readmits,
and a shorter length of stay in hospitalized patients (Wonders et al., 2019).
A total annual expense of $61,500 for the certified trainer and essential equipment is far
exceeded by the potential hospitalizations of the twenty projected study participants, necessary
medications to reduce side effects, and wasted costs of missed chemotherapy infusions. With
health care and chemotherapy costs constantly rising, cancer patients are three times more likely
than those without cancer to file for bankruptcy and be met with unrealistic financial burdens
(Wonders et al., 2019). Financially speaking, the low costs and abundant benefits from a simple
exercise intervention far exceed the anticipated expenses to limit patients to treatment without
physical activity.
8. Overall Discussion / Results
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Since this exercise intervention project is a benchmark, there are no official results or
evaluations yet at this time. The clinic director and multiple providers have expressed interest
and positive feedback in regard to implementing this project on a future date when there are not
so many concerns or restrictions regarding COVID-19 safety and prevention. The budget for
financing is being reviewed for approval of incorporating this program into the optional and
rarely used fitness program that is already present at the facility.
For this project to be deemed successful, at least twenty willing patients diagnosed with
cancer must complete this twelve-week exercise program and associated CRF questionnaires.
Successful CRF reduction will be defined as greater than a 20 percent decrease from baseline to
week twelve in total scores from the questionnaires that are distributed. Realistic goals for this
project have been set so successful achievement of the expected outcomes are anticipated when
this project is implemented into practice.
9. Recommendations
While physical activity should be encouraged for all patients, it is especially important to
focus on cancer patients and their need to reduce treatment related side effects including CRF. It
has been found that the effects of exercise are greatly enhanced when the patient is supervised
and the plan is individualized by the provider to tailor to his or her unique needs (MenesesEchávez et al., 2015). The current standard of not discussing physical activity or CRF
prevention with patients is not considered best practice based on the evidence.
In order for patients to have the most independence with activities of daily living and the
highest quality of life, it is recommended that patients initiate exercise including supervised
training at least three times a week for one-hour sessions during this program. Cost effectiveness
has been demonstrated in that this physical activity may help patients of employment age return
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to work sooner and reduce the amount of sick days needed (Mijwel et al., 2019). It is, therefore,
recommenced to incorporate individualized physical activity into the treatment regimen for
cancer patients undergoing chemotherapy.
When this project is able to be implemented, it is recommended that the next step after
completion be to set a standard protocol treatment including exercise in all oncology clinics.
Patients, leaders, and healthcare staff will need to work together as a team to move mountains
and ensure that the best quality care is being provided to promote the best quality of life.
Conclusion
As an advanced practice provider, it will be beneficial to add the topic of exercise to the
chemotherapy education sessions prior to starting treatments. Some benefits of decreased CRF
include improving quality of life, increasing functioning with activities of daily living, reducing
depression and anxiety, and decreased mortality rates. Adding such a simple intervention of
physical activity can make a dramatic difference in patient outcomes at one of the most stressful
points of their lives. Following the consistent evidence for change and implementing the
individualized exercise program has the potential to affect future protocols and lives of all
oncology patients undergoing treatment.
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Appendix A: Evaluation Table

PICOT Question: In oncology patients (P), how does a regular exercise program (I) compared to no exercise program (C) affect cancer-related fatigue (O)
during the first three months of treatment (T)?
PICOT Question Type (Circle): Intervention Etiology

Diagnosis or Diagnostic Test Prognosis/Prediction Meaning

Caveats
1) The only studies you should put in these tables are the ones that you know answer your question after you have done rapid
critical appraisal (i.e., the keeper studies)
2) Include APA reference
3) Use abbreviations & create a legend for readers & yourself
4) Keep your descriptions brief – there should be NO complete sentences
5) This evaluation is for the purpose of knowing your studies to synthesize.

Citation:
(i.e.,
author(s),
date of
publication,
& title)
Author,
Year, Title

Conceptual
Framework
Theoretical
basis for
study
Qualitative
Tradition

Design/
Method

Sample/
Setting
Number,
Characteristi
cs,
Attrition rate
& why?

Major
Variables
Studied and
Their
Definitions
Independent
variables
(e.g., IV1 =
IV2 =)
Dependent
variables (e.g.,
DV = )

Measurement of
Major Variables
What scales were
used to measure
the outcome
variables (e.g.,
name of scale,
author, reliability
info [e.g.,
Cronbach
alphas])

Data
Analysis
What stats
were used
to answer
the
clinical
question
(i.e., all
stats do
not need
to be put
into the
table)

Study Findings
Statistical findings or
qualitative findings (i.e.,
for every statistical test
you have in the data
analysis column, you
should have a finding)

Strength of the Evidence (i.e., level of evidence
+ quality [study strengths and weaknesses])
• Strengths and limitations of the study
• Risk or harm if study intervention or
findings implemented
• Feasibility of use in your practice
• Remember: level of evidence (See Melnyk
& Finout-Overholt, pp. 32-33) + quality of
evidence = strength of evidence & confidence
to act
• Use the USPSTF grading schema
http://www.ahrq.gov/clinic/3rduspstf/ratings.h
tm

CANCER-RELATED FATIGUE

26
Appendix A: Continued

Rogers, L. Q.,
Courneya, K.
S., Anton, P.
M., Verhulst,
S., Vicari, S.
K., Robbs, R.
S., &
McAuley, E.,
2017, Effects
of a
multicompon
ent physical
activity
behavior
change
intervention
on fatigue,
anxiety, and
depressive
symptomatol
ogy in breast
cancer
survivors:
Randomized
trial

None
specifically
stated

RCT

N=222 BCS
110 BEAT
Cancer EP
112 usual care
2 Midwestern
&1
Southeastern
academic
Institutions
MA 54.4
YOE 15.5
Race: 84%
white, 11%
AA, 5% other
CS: 11%
DCIS, 42%
stage 1, 35%
stage 2, 12%
stage 3
MMSCD: 54
Tx Hx: 58%
chemo, 68%
XRT, 49% HT
Attrition rate:
retention rate
97% at M3
and 96% at
M6

IV = EP
DV = CRF,
anxiety, &
depression

FSI, Hann, CA
>.90

CI

HADS, Zigmond
& Snaith, CA .82
depression, CA.83
anxiety

ES
SS

BEAT cancer effect on
fatigue:
M= - 0.61; 95% CI = -1.04
to – 0.19; d=- 0.32; P=
.004 at M3

Strengths: RCT design, multicenter
implementation, excellent retention
rates

•

Limitations: small percent of ethnic
minorities, unknown generalizability
to survivors of cancer types, focused
on physical activity alone

•

Risk: minimal

•

Feasible to implement exercise
program in post-treatment oncology
patients

•

Level of evidence: 2-RCT

•

USPSTF Grade B – Offer this service
to patients
Moderate certainty that the net benefit
is substantial
Moderate level of certainty

M=- 0.46; 95% CI – 0.89
to – 0.03; d= - 0.26; P =
.038 at M6

Mean
Adjusted
linear
mixed
models
with
unstructure
d
covariance
matrix

•

Reductions in fatigue
interference:
M = -0.84; 95% CI = 1.26 to – 0.43; d= -0.40;
P< .001 at M3 and – 0.66;
CI – 1.08 to – 0.24; d = 0.35; P = .002 at M6
Reductions in depression:
M = - 1.31; 95% CI = 1.98 to – 0.64; d = - 0.38;
P < .001 at M3 and M= 0.71; 95% CI = -1.39 to 0.02; d = -0.21; P = .042 at
M6
Reductions in anxiety:
M= -1.25; 95% CI = -1.98
to –0.53; d = -0.33; P<
.001 at M3 and M= -0.75;
CI= -1.49 to -0.02; d = 0.21; P = .044 at M6
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MenesesEchávez, J.
F., GonzálezJiménez, E.,
& RamírezVélez, R.,
2015, Effects
of supervised
multimodal
exercise
interventions
on cancerrelated
fatigue:
Systematic
review and
meta-analysis
of
randomized
controlled
trials

None
specifically
stated

Systemat
ic review
and
metaanalysis

N = 9 RCTs
772 total
cancer
patients in all
studies

IV: exercise
interventions
including AE,
RT, & ST
DV: CRF

FACT Fatigue
scale, Yellen,
Cella, Webster,
Blendowsky,
Kaplan; CA not
noted

SMD
CI

Final sample:
635 records
identified with
only 9
included after
evaluation
EP avg 16.5
weeks with
avg of 3
sessions per
week. Mean
duration 45
min
> 18 yrs old
MA 55.5
54.2% female
Tx hx: during
treatment
Chemo
MMSCD: 8.2
Cancer: breast
Attrition rate:
N/A

EORTC QLQC30, Aaronson,
Ahmedzai,
Bullinger, et al.,
CA not noted

Strengths:
- search criteria stated
- summary of full search strategy
(Appendix)
- selection criteria verified
independently by 2 blinded authors
- risk of bias scored by pedro scale
- inclusion of meta-analysis

•

Limitations:
- average score of study quality >
average score for trials in
physiotherapy
- risk of bias was evaluated by one
author
- Considerable statistical
heterogeneity was present in all effect
estimates
- more info needed about effects of
initial chemo & XRT on muscle
satellite cells that proliferate in
response to supervised multimodal
exercise

•

Risk for harm: minimal; muscle
strain/injuries

•

Feasible to implement AE, RT, & ST
in cancer survivors receiving
treatment and post-treatment

•

Level of evidence: 1 – systematic
review & meta-analysis

•

USPSTF: Grade B – offer this service
to patients
Moderate certainty that the net benefit
is moderate
Moderate level of certainty

SMD = -0.23; 95% CI 0.37 to -0.09 P = 0.001
with low statistical
heterogeneity I2= 46.7%
7 studies implemented
multimodal exercise
interventions including
AE, RT, & ST:

Piper Fatigue
Scale, Piper et al.,
CA not noted

SMD = -0.35, 95% CI 0.62 to -0.08 P=0.01

Schwartz Cancer
Faituge Scale,
Schwartz, CA not
noted

2 studies evaluated effects
of RT:
SMD = -0.17, 95% CI 0.50 to 0.15 P=0.30

Multidimensional
Fatigue Inventory;
Smets, Garssen,
Bonke, De Haes,
CA not noted

CRF in cancer patients
receiving anticancer
treatment:

Pedro Scale,
Verhagen, CA not
noted
Interrater
reliability
determined by
Cohen’s kappa
Mean kappa =
0.81

•

SS
H

Primary
search:
PubMed,
CENTRAL,
EMBASE, &
OVID JanMar 2014

Supervised multimodal
exercise interventions in
cancer survivors –
combined 9 studies:

Metaregres
sion model

SMD = -0.23, 95% CI 0.39 to -0.07, P<0.0001
with moderate
heterogeneity I2= 64%

Tau-squared = 0.04,
P=0.04
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Oertle, S.,
Burrell, S., &
Pirollo, M.,
2016,
Evaluating
the effects of
a physicianreferred
exercise
program on
cancerrelated
fatigue and
quality of life
among early
cancer
survivos

The Neuman
Systems
Model

Quasiexperim
ental
study

N=38 cancer
survivors

IV: physicianreferred EP

70 originally
recruited

DV: CRF &
QOL

All
participants
from 1 not
specified
cancer center
accredited by
the American
College of
Surgeons
Commission
on Cancer
Sex: F-71.1%,
M-28.9%
Race: white –
81.6%, AA18.4%
Ethnicity:
non-H/L97.4%, H/L2.6%
Cancer type:
breast -47.4%,
Lung – 10.5%,
colorectal –
10.5%,
Prostate –
7.9%, Head &
neck – 7.9%
Lymphoma –
7.9%, Ovarian
– 5.3%,
Endometrial –
2.6%
Attrition rate:
54%
completed 60day PREP;
46% dropped
out

Brief Fatigue
Inventory Scale,
Mendoza et al.,
CA 0.96

Mean
paired
difference

Global CRF from prePREP to post-PREP: 1.99
(95% CI, 1.19, 2.77; t(37)
= 5.11; P=.0000; d=0.83)

•

Strengths:
-PREP was implemented by CETcertified medical fitness specialists
-CET specialists provided
standardization & control to the
exercise intervention.
-Individualized the program based on
each survivor’s health status.
-Timing during early survivorship
phase

•

Limitations:
-Quasi-experimental design
-Low completion rate (54%)
-Convenience sampling
-Only 1 community cancer center used
-Relatively small sample size that
consisted of increased proportion of
young white women

•

Risk for harm: minimal; injuries
possible from treadmill, elliptical,
bicycle, resistance bands, stretching
equipment. No risks discussed or
noted among study population.

•

Feasible to implement PREP in early
cancer survivors

•

Level of evidence: 3-Non RCTs

•

USPSTF: Grade B – Offer this service
to patients.
Moderate certainty that the net benefit
is substantial
Moderate level of certainty

CI
EORTC QLQC30, Aaronson,
Ahmedzai,
Bullinger, et al.,
CA 0.52-0.89

t-test
SS
ES

CRF from pre-PREP to
post-PREP: 1.64 (95% CI,
0.95, 2.32; t(37) = 4.84;
P=.000; d=0.79)
CRF interference: 2.18
(95% CI, 128, 3.07; t(37) =
4.94; P=.000; d=0.80)
Physical functioning
scores: -14.21 (95% CI, 20.13, -8.29; t(37)= -4.86;
P=.0000; d=0.86)
Role functioning: -21.93
(95% CI, -32.13, -8.29;
t(37)= -4.23; P=.0001;
d=0.67)
Social functioning: -30.84
(95% CI, -30.84, -9.51;
t(37)= -3.83; P=.0005;
d=0.62)
Overall QOL: -12.28 (95%
CI, -19.39, -5.17, t(37)= 3.50; P=.0012; d=0.57)
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Patel, J. G.,
& Bhise, A.
R., 2017,
Effect of
aerobic
exercise on
cancerrelated
fatigue

None
specifically
stated

RCT

N= 25 cancer
patients
Took place in
Gujarat, India
Group A: 12
patients in
aerobic
intervention
group
Group B: 13
patients in
control
stretching
group
55 patients
screened
34 patients
eligible
Age:
Group A:
49.08
Group B:
50.62
Sex: A- 6
male, 6 female
B-8 male, 5
female

IV: aerobic
exercise
program vs
Home
stretching
DV: CRF,
QOL, physical
performance

Borg scale, Dr.
Gunnar Borg, CA
not noted

SD

SS shown by mean
changes in BFI, FACT-G,
& 6MWT:

•

Strengths:
-none specifically stated
-RCT design
-Length of program
-Beneficial effects on fatigue

•

Limitations:
-Small sample size
-Long-term follow up not carried out
-Poor retention rates

•

Risk for harm: minimal; potential
injuries during aerobic activity

•

Feasible to implement aerobic
exercise program in cancer patients
post treatment with chemo or XRT

•

Level of evidence: 2-RCT

•

USPSTF: Grade B – Offer this service
to patients.
Moderate certainty that the net benefit
is moderate.
Moderate level of certainty due to
sample size

SS
Brief Fatigue
Inventory Scale,
Mendoza et al.,
CA not noted

Group A (Aerobic
exercise)
W
U

6MWT, American
Thoracic Society,
CA not noted
FACT-General,
Cella, CA not
noted
reliability of scales
not noted

Mean

Pre-intervention
BFI: 5.77 ± 1.12
FACT-G: 74.92 ±
5.43
6MWT: 305.6 ±
27.72
Post-intervention
BFI: 3.85 ± 0.91
FACT-G: 85.17 ± 5.84
6MWT: 337.2 ± 27.19
BFI W: 78, P= 0.0025
FACT-G W: -78,
P=0.0025
6MWT W: -78, P=0.0025
Group B (Postintervention)
Pre-intervention
BFI: 5.93 ± 1.24
FACT-G: 74.54 ± 5.39
6MWT: 307.5 ± 33.58
Post-intervention
BFI: 5.72 ± 1.45
FACT-G: 76.08 ± 6.27
6MWT: 313.5 ± 30.60

Diagnosis:
Breast-10, GI9,
Gynecological
– 6, Head &
neck – 9

BFI W: 48, P= 0.063
FACT-G W: -32, P=0.222
6MWT W: -59, P=0.0423

Treatment:
Chemo-13,
XRT – 10,
combo – 11

BFI:
A- 1.91 ± 0.57
B-0.21 ± 0.39
U 0.50, P<0.0001

SS shown by mean
difference in Group A & B

CANCER-RELATED FATIGUE

Time since
treatment
completion:
< 6 months:
17, >6-12
months: 8, 1218 months: 5,
>18 months: 4
Attrition Rate:
5 dropped out
of group A d/t
social reasons,
recurrence of
tumor, patient
wishes.
4 dropped out
of group B d/t
lack of
response,
tumor
recurrence

30

FACT:
A- 10.25 ± 5.34
B- 1.53 ± 3.88
U 7.00, P=0.0001
6MWT:
A – 31.50 ± 14.82
B – 1.92 ± 3.54
U 1.50, P< 0.0001
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Tian, L., Lu,
H., Lin, L., &
Hu, Y., 2016,
Effects of
aerobic
exercise on
cancerrelated
fatigue: A
meta-analysis
of
randomized
controlled
trials

None
specifically
stated

Metaanalysis

N= 26 RCTs
2830 cancer
patients in all
studies – 1426 in
AE group, 1404
in control arm
Primary search:
The Cochrane
Central Register
of Controlled
Trials, Embase,
MEDLINE,
Web of Science,
China Biology
Medicine, &
China National
Knowledge
Infrastructure in
December 2014
MA: 40-70.6
Ethnicity: 11White, 4-Asian
CS-I-III
13-breast
2-prostate
2-colorectal
2nasopharyngeal
2- hematological
1-gynecologic
3- other
Attrition Rate:
0%

IV: Aerobic
exercise versus
usual care/no
exercise

POMS scale,
McNair, Lorr, &
Doppleman, CA
not noted

SMD

DV: CRF

LASA scale,
Priestman &
Baum, CA not
noted

WMD

FACT-Fatigue
scale, Yellen,
Cella, Webster,
Blendowsky,
Kaplan; CA not
noted

SS
CI

I2
X2

AE effect on CRF overall
SMD= -0.22, 95% CI, (-0.39, -0.04)
P=0.01

•

Strengths:
-Highest level of evidence
-RCTs only used
-search criteria stated
-Third reviewer used to solve
discrepancies
-Large sample size of studies

•

Limitations:
-Large number of breast cancer
patients limiting generalizability
-10 of the studies had a sample size
smaller than 30 people
-Pain, emotional distress, sleep
disturbance, anemia, nutrition, activity
level, medication side effects profile,
alcohol/substance abuse, &
comorbidities not included

•

Risk for harm:
-Minimal; lymphedema, foot fracture,
bronchitis, lightheadedness, nausea,
dizziness, diarrhea, pulmonary
embolism, heart palpitations, dyspnea
are all AE’s reported

8 weeks of AE
SMD = -0.73, 95% CI (-1.19, -0.27)
P < 0.01

•

Feasible to implement AE program in
cancer patients to reduce CRF

Walking has moderate effect on
CRF
SMD = -0.53, 95% CI (-0.94, -0.11)
P = 0.01

•

Level of evidence – 1 Meta-analysis

•

USPSTF: Grade B – Offer this
service to patients.
There is high certainty that the net
benefit is moderate due to individual
study sample sizes.
High level of certainty

AE has moderate effect on CRF
compared to control
SMD= -0.63, 95% CI (-0.98, -0.27),
P < 0.01
AE significantly reduces fatigue
with nasopharyngeal carcinoma
patients
SMD= -0.91, 95% CI, (-1.27, -0.56)
P < 0.01
Professionally led AE training
SMD= -0.24, 95% CI (-0.45, -0.03),
P= 0.02
20-30 min AE
SMD= -0.36, 95% CI (-0.63, -0.09)
P < 0.01

Brief Fatigue
Inventory Scale,
Mendoza et al.,
CA not noted

50 min AE
SMD= -1.33, 95% CI (-2.42, -0.24,
P = 0.02

Piper Fatigue
Scale, Piper et al.,
CA not noted

3 sessions per week
SMD = -0.37, 95% CI (-0.65, -0.09)
P = 0.01

Revised Piper
Fatigue Scale,
Piper et al., CA
not noted

2 sessions per week
SMD= -0.95, 95% CI (-1.36, -0.54)
P < 0.01

Trials that used FACT-Fatigue scale
WMD=1.46, 95% CI (0.03, 2.89),
n=12 studies, P < 0.05
Trials that used brief fatigue
inventory scale
WMD= -5.27, 95% CI (-8.38, -2.15)
n= 3 studies, P < 0.01
Trials that used the revised piper
fatigue scale
WMD= -1.02, 95% CI (-1.70, -0.34)
n=5 studies, P < 0.01
X2= 158.55
I2= 78%
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Witlox, L.,
Hiensch, A.
E., Velthuis,
M. J., Steins
Bisschop, C.
N., Los, M.,
Erdkamp, F.
L. G.,
Bloemendal,
H. J.,
Verhaar, M.,
Huinink, D.
B., Wall, E.,
Peeters, P. H.
M., & May,
A. M.,
(2018). Fouryear effects
of exercise
on fatigue
and physical
activity in
patients with
cancer.

None
specifically
stated

RCT

N = 128
patients
Intervention
group = 70
patients
Usual care =
58 patients
MA 51.1
Breast cancer
= 110 patients
Colon cancer
= 18 patients
TNBC 20.2%
Postmenopausal
40.3%
Attrition Rate:
54 patients
were lost to
follow-up.

IV = Aerobic
and muscle
strength EP vs.
usual care
DV = CRF and
physical
activity

Multidimensional
Fatigue Inventory;
Smets, Garssen,
Bonke, De Haes,
CA not noted

CI

SQUASH; Dutch
National Institute
of Public Health
and the
Environment; CA
not noted

SD

ES
Mean

General Fatigue
EP:
Mean 10.24; SD 4.92
CI: -0.41 [-1.52, 0.71]
ES: 0.08
Usual Care:
Mean 10.67; SD 4.80
CI: -0.63 [-1.81, 0.56]
Physical Fatigue
EP:
Mean 9.92; SD 5.12
CI: -1.00 [-2.17, 0.18]
ES: 0.22
Usual Care:
Mean 10.54; SD 5.01
CI: -0.55 [-1.79, 0.70]
Physical Activity
EP:
Mean 583.91; SD 658.73
CI: 43.22 [-102.13,
188.57]
ES: 0.22
Usual Care:
Mean 627.31; SD 637.11
CI: -143.77 [-298.43,
10.89]

•

Strengths:
- Randomized design
- 4-year long term follow-up
- Intention to treat analysis

•

Limitations:
- High attrition rate of lost to followup patients
- Participants had high pre-diagnostic
physical activity levels
- Large number of breast cancer
patients
-Reliance on self-reported measures

•

Risk for harm: Minimal; none
reported

•

Feasible to implement exercise during
chemotherapy to reduce CRF

•

Level of evidence: 2 – RCT

•

USPSTF: Grade B – Offer this service
to patients.
High level of certainty that the net
benefit is moderate.
High level of certainty.
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Mijwel, S.,
Jervaeus, A.,
Bolam, K. A.,
Norrbom, J.,
Bergh, J.,
Rundqvist,
H., &
Wengström,
Y. (2019).
Highintensity
exercise
during
chemotherap
y induces
beneficial
effects 12
months into
breast cancer
survivorship.

None
specifically
stated

RCT

N = 173
patients
(RT-HIIT)
High intensity
aerobic
interval
training with
RT = 62
(AT-HIIT)
Moderate
intensity
aerobic
training = 59

IV: Aerobic
Interval training
with RT vs
Aerobic
training vs
Usual care
DV: CRF,
QOL, symptom
burden, muscle
strength,
cardiorespirator
y fitness, body
mass, & return
to work

Piper Fatigue
Scale, Piper et al.,
CA not noted

Mean

EORTC QLQC30, Aaronson,
Ahmedzai,
Bullinger, et al.,
CA 0.52-0.89

CI

Memorial
Symptom
Assessment Scale,
unknown author,
CA 0.83-0.88

Effects on CRF at 12
months:

•

Strengths:
- Limited loss to follow up
- High response rate
- In-clinic measurements of objective
muscle strength, cardiorespiratory
fitness, and body mass
- Usual care group used as control
through entire follow up

•

Limitations:
- More active sample that completed
physiological in-clinic assessments
-PA not measured objectively at all
time points
-Lack of detailed info about type and
intensity of exercise performed

•

Risk for harm: Minimal; none
specifically discussed

•

Feasible to have patients in the
oncology clinic participate in an
aerobic exercise program to reduce
CRF

•

Level of Evidence: 2 RCT

•

USPSTF: Grade B – offer this service
to patients. Moderate level of
certainty that the net benefit is
moderate
Moderate level of certainty

SD

P value

RT-HIIT:
Mean + SD – 2.80±2.64
95% CI (-2.25, -0.21)
p = 0.012
ES = -0.34

ES
AT-HIIT:
Mean + SD – 2.58±2.55
95% CI (-2.14, -0.09)
p = 0.029
ES = -0.10
Effects on QOL:

(UC) Usual
Care = 52
MA:
-RT-HIIT:
52.7
-AT-HIIT:
54.4
-UC: 52.6
TNBC:
-RT-HIIT:
14.9
-AT-HIIT:
11.0
-UC: 16.7
Attrition Rate:
Declined to
participate: 34
Discontinued
intervention:
24
Lost to follow
up: 9

RT-HIIT:
Mean + SD – 73.41±20.57
95% CI (-3.81, 10.93)
P = 0.734
ES = 0.30
AT-HIIT:
Mean + SD – 77.12 ±13.54
95% CI (-1.30, 13.52)
P = 0.143
ES = 0.36
Effects on Physical
functioning:
RT-HIIT:
Mean + SD – 91.58±13.77
95% CI (-2.13, 9.49)
P = 0.383
ES = 0.26
AT-HIIT:
Mean + SD – 91.87±13.55
95% CI (-1.59, 10.06)
P = 0.241
ES = 0.27
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Al Maqbali,
M., Hughes,
C.,
Dunwoody,
L., Rankin, J.
P., Hacker, E.
D., & Gracey,
J. (2019).
Exercise
interventions
to manage
fatigue in
women with
gynecologic
cancer: A
systematic
review.

None
specifically
stated

Systemat
ic
Review

N = 5 studies
2 RCTs
3 single-arm
trials
209
participants
Primary
search:
CINAHL,
MEDLINE,
EMBASE,
PsycINFO, &
Cochrane
Library
-Age: 53-58.6
-gynecologic
cancer
-Any stage of
dx
-English
Attrition rate:
231 articles
excluded by
title &
abstract; 9
articles did not
meet
eligibility
criteria

IV: Homebased exercise
interventions
DV: CRF

FACT-Fatigue
scale; Yellen,
Cella, Webster,
Blendowsky,
Kaplan; CA not
noted

SS

Strengths:
-highest level of evidence
-strict inclusion criteria
-quality assessment checklists used
-Long-term follow-ups done

•

Limitations:
-Home-based exercise programs
-Compliance not measured
-Limited to 5 studies
-CRF not primary outcome in some
studies

•

Risk for harm: minimal; none
discussed

•

Feasible to have outpatient oncology
patients participate in home-based
exercise interventions to improve CRF

•

Level of evidence: 1 – Systematic
Review

•

USPSTF: Grade B – offer this service
to patients. Moderate level of
certainty that the net benefit is
moderate
Moderate level of certainty

-significant improvement
in fatigue: 3 studies
(p=0.017; p=0.004;
p=0.01)

Multidimensional
Fatigue Inventory;
Smets, Garssen,
Bonke, De Haes;
CA not noted

- ↑ physical functioning: 3

Quality of Life in
Adult Cancer
Survivors; Avis,
Smith, McGraw,
Smith, Petronis,
Carver; CA 0.72

- ↑ sleep quality: 3 studies

Somatic
Psychological
Health Report
scale; unknown
author; CA>0.78

•

studies

-No difference: 2 studies
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Brown, J. C.,
Damjanov,
N., Courneya,
K. S., Troxel,
A. B., Zemel,
B. S., Rickels,
M. R., Ky, B.,
Rhim, A. D.,
Rustgi, A. K.,
& Schmitz, K.
H. (2018). A
randomized
doseresponse
trial of
aerobic
exercise and
healthrelated
quality of life
in colon
cancer
survivors

None
specifically
stated

RCT

N = 39 colon
cancer
survivors
-Age > 18
-completed tx
within 36
months of
study
-Stage I-III
colon cancer
-Ability to
walk for 6 min
-No surgeries
planned
during the
intervention
Attrition rate:
not discussed
in the study

IV:
Usual care
Vs
Low-dose
aerobic exercise
(150 min/wk)
Vs
High-dose
aerobic exercise
(300 min/wk)
DV:
QOL, sleep,
CRF, physical
functioning,
mental health

Medical Outcome
Survey Short
Form; Rand
Corporation; CA
not included
FACT -Colorectal;
Ward, Hahn, Mo,
Hernandez,
Tulsky, Cella; CA
not included
Pittsburgh Sleep
Quality Index;
Buysse, CA not
included
Fear of Cancer
Recurrence
Inventory; Simard
& Savard; CA not
included
FSI, Hann, CA
>.90
North Central
Cancer Treatment
Group
questionnaire;
NCCTG; CA not
included

•

Strengths:
-Randomized design
-90% adherence
-97% completion rate
-21% non-white race
-well-validated questionnaires used

•

Limitations:
-Small sample size
-non-statistically significant
differences in baseline QOL values
-Study participants not blinded
-Social desirability bias cannot be
excluded
-Type I error rate not adjusted

Sleep quality:

•

Risk for harm: minimal; not discussed

Low dose - -0.3±1.0;
p=0.799 SMD= -0.11
High dose - -1.1±1.0;
p=0.336 SMD= -0.30
*significant improvements

•

Feasible to implement high dose
physical activity of 300 min/wk in
outpatient oncology patients receiving
treatment

•

Level of evidence – 2 RCT

•

USPSTF: Grade B; There is a
moderate level of certainty that the net
benefit is substantial.

Mean

Physical Health:

SD

Low dose – 1.2±6.3;
p=0.506
High dose – 13.1±6.5;
p=0.002
*significant high dose

Standard
error
SS
SMD

Mental Health:
Low dose - -3.4±4.1;
p=0.405
High dose- 1.4±4.2;
p=0.749
*not significant

CRF:
Low dose – 0.8±3.5;
p=0.817 SMD=0.08
High dose - -6.0±3.6;
p=0.096 Ptrend=0.045
*Significant improvement
in high dose
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Kampshoff,
C. S.,
Chinapaw,
M. J. M.,
Brug, J.,
Twisk, J. W.
R., Schep, G.,
Nijziel, M. R.,
van
Mechelen,
W., &
Buffart, L. M.
(2015).
Randomized
controlled
trial of the
effects of
high intensity
and low-tomoderate
intensity
exercise on
physical
fitness and
fatigue in
cancer
survivors:
Results of
the
resistance
and
endurance
exercise after
chemotherap
y (REACT)
study

None
specifically
stated

RCT

N= 277 cancer
survivors
HI exercise
=91
LMI exercise
= 95
WLC exercise
= 91
->18 y/o
-181 breast
cancer
-49 colon
cancer
-12 ovarian
cancer
-26 lymphoma
-4 cervical
-5 testicular
-Stage I-II:
187
-Stage III-IV:
90
Attrition rate:
5 – disease
recurrence
4comorbidities
not related to
interventions
(heart failure,
ankle fx, etc),
6 – didn’t
want to do the
exercise
11musculoskelet
al problems

IV:
High intensity
(HI)
Vs
Low-tomoderate (LMI)
Resistance &
endurance
exercise
Vs.
wait list control
(WLC)
DV:
Cardiorespirato
ry fitness
Muscle strength
CRF

Cardiorespiratory
– maximal
exercise test on
electronically
braked cycle
ergometer

CI 95%
Beta
Mean

Muscle strength –
JAMAR hand gri
dynamometer
CRF –
Multidimensional
Fatigue Inventory;
Smets, Garssen,
Bonke, De Haes;
CA not noted
QOLEORTC QLQC30, Aaronson,
Ahmedzai,
Bullinger, et al.,
CA 0.52-0.89
HADS, Zigmond
& Snaith, CA .82
depression, CA.83
anxiety
Pittsburgh Sleep
Quality Index;
Buysse, CA not
included

SD

Cardiorespiratory fitness:
HI- β 2.2 (1.2 to 3.1)
LMI β 1.3 (0.3 to 2.3)
WLC Mean(SD): 23.8 (5.9)
*significant improvements
compared to WLC
Muscle Strength:
HI β 0.2 (-0.8 to 1.1)
LMI β 0.6 (-0.3 to 1.5)
WLC: 18 (3.9)
*improved, but not
significant
CRF:
HI β -1.3 (-2.2 to -0.4)
LMI β -1.1 (-2.0 to -0.2)
WLC: 11.3 (4.1)
*significant improvements
compared to WLC
Physical Functioning
HI β 3.1 (0.7 to 5.5)
LMI β 4.1 (1.6 to 6.6)
WLC: 84.1 (13.1)
*significant improvements
compared to WLC
QOL
HI β 5.9 (2.0 to 9.8)
LMI β 3.3 (-0.6 to 7.1)
WLC: 75.3 (15.4)
*significant improvements
compared to WLC

•

Strengths:
-direct comparison between HI & LMI
-blinded outcome
-Concealed allocation
-Large sample size
-Reliable outcome measures
-Intention-to-treat analysis

•

Limitations
-effect sizes interpreted as modest
-full report on adherence needed
-8% of WLC engaged in exercise
-Majority of patients were breast
cancer

•

Risk for harm: No adverse effects
were experienced from study

•

Feasible to implement this in my
outpatient oncology clinic facility

•

Level of evidence – 2 RCT

•

USPSTF: Grade B; There is a
moderate level of certainty that the net
benefit is substantial.
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Gheyasi, F.,
Baraz, S.,
Malehi, A.,
Ahmadzadeh
, A., Salehi,
R., &
Vaismoradi,
M. (2019).
Effect of the
walking
exercise
program on
cancerrelated
fatigue in
patients with
acute
myeloid
leukemia
undergoing
chemotherap
y

Bandura
Self-Efficacy
Theory
(BSET)

Quasiexperim
ental
study

N = 50
patients with
AML
->18 y/o
(mean age 37)
-Diagnosed
with acute or
recurrent
AML
-at least 2
chemo
sessions
-No
cardiovascular
dx, DM, HTN,
or other CA
hx
-Mostly male
(60%)
-Married
(50%)
Undergraduate
(32%)
-Employees
(46%)
Attrition rate:
Estimated
10%
anticipated;
actual percent
not revealed

IV:
Walking
exercise
program

Brief Fatigue
Inventory Scale,
Mendoza et al.,
CA 0.89

Strengths:
-Reliable measuring methods
-Strict inclusion/exclusion criteria
-low-cost method
-Easy instructions for patients

On day 56.16 ± 1.16

•

On day 10 –
5.84 ±1.34

•
•
•

Limitations
-Small sample size
-Limited age range
-Limited to one hospital
-No control group

CRF Mean & SD:

SD

Before intervention7.2 ± 1.15

SS
DV:
CRF

•

Mean

p<0.001

•

Risk for harm: No adverse effects
were experienced from study

•

Before intervention –
41 ± 7.3

Feasible to implement this in my
outpatient oncology clinic facility

•

On day 5:
34.5 ± 5.9

Level of evidence – 3: Quasiexperimental study

•

USPSTF: Grade B; There is a
moderate level of certainty that the net
benefit is substantial.

CRF interference in Daily
Life Activities:

On day 10:
28.5 ± 6.04
p<0.001
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Marker, R. J.,
Cox-Martin,
E.,
Jankowski, C.
M., Purcell,
W. T., &
Peters, J. C.
(2018).
Evaluation of
the effects of
a clinically
implemented
exercise
program on
physical
fitness,
fatigue, and
depression in
cancer
survivors

None
specifically
stated.

Quasiexperim
ental
study

N = 170
cancer
survivors
-Age 57±12
years (range
28-89)
-69% women
-50% receiving
cancer
treatments
-37% breast
cancer
Attrition rate:
50 participants
lost to followup; retained
71%

IV:
exercise
training
sessions
DV:
Cardiorespirato
ry Fitness,
Muscular
strength,
CRF,
Depression

Piper Fatigue
Scale Piper et al.,
CA not noted
Beck Depression
Inventory; Beck,
Steer, & Garbin;
CA 0.86

Paired t
tests
Mean
SD
Effect size

Baseline:

•

Strengths:
-Study approved by IRB
-Reliable measurement forms used
-Cancer Exercise Specialist led
training sessions
-Exercise programs were
individualized
-More diverse cancer population

•

Limitations:
-Retrospective data used from a
convenience sample
-No control group
-Small number of outcome measures
collected
-Community-based program
-No hypothesis

•

Risk for harm: No adverse effects
were experienced from study

•

Feasible to implement this in my
outpatient oncology clinic facility

•

Level of evidence – 3: Quasiexperimental study

•

USPSTF: Grade B; There is a
moderate level of certainty that the net
benefit is substantial.

VO2peak: 21.8±7
Strength: 29.2±10
CRF: 4.5 ±2
Depression: 10.5±7
Paired t-tests between
baseline & follow up and
effect size at end of
intervention:
VO2peak: 3.0±4.0; 0.8
Strength: 1.0±2.0; 0.3
CRF: -1.0±2.0; -0.5
Depression: -2.7±5.7; -0.5
All significantly improved
from baseline to follow-up
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Legend:
RCT – randomized controlled trial
IV = independent variable
DV = dependent variable
CRF = cancer-related fatigue
FSI = fatigue symptom inventory
CA = Cronbach’s alpha
HADS = Hospital Anxiety and Depression Scale
USPSTF = U.S. Preventive Services Task Force
BCS = breast cancer survivors
BEAT = Better Exercise Adherence after Treatment for Cancer
EP = exercise program
MA = mean age
YOE = years of education
AA = African American
CS = cancer stage
MMSCD = mean months since cancer diagnosis
Tx Hx = treatment history
HT = hormone therapy
XRT = radiation therapy
CI = confidence interval
SS = statistical significance
ES = effect size
3MFU = 3-month follow up
PI = post intervention
MBGD = mean between group difference
FACT = Functional Assessment of Cancer Therapy
EORTC QLQ-C30 = European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
H = Heterogeneity
AE = aerobic exercise
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RT = resistance training
ST = stretching
H/L = Hispanic/Latino
QOL = quality of life
PREP = physician-referred exercise program
6MWT = 6-minute walk test
W: Wilcoxon matched-pairs test
POMS = Profile of Mood States
LASA = Linear Analog Self-Assessment
TNBC = triple negative breast cancer
RT-HIIT = High intensity aerobic interval training
AT-HIIT = moderate intensity aerobic training
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PIPER FATIGUE SCALE (PFS)
Directions: Many individuals can experience a sense of unusual or excessive tiredness whenever
they become ill, receive treatment, or recover from their illness/treatment. This unusual sense of
tiredness is not usually relieved by either a good night’s sleep or by rest. Some call this symptom
“fatigue” to distinguish it from the usual sense of tiredness.
For each of the following questions, please fill in the space provided for that response that best
describes the fatigue you are experiencing now or for today. Please make every effort to answer
each question to the best of your ability. If you are not experiencing fatigue now or for today, fill
in the circle indicating “0” for your response. Thank you very much!
1. How long have you been feeling fatigue? (Check one response only).
1. not feeling fatigue
2. minutes
3. hours
4. days
5. weeks
6. months
7. other (Please describe) _______________________________________________
2. To what degree is the fatigue you are feeling now causing you distress?
No Distress
1
2.
3.

4

5

6

7

8.

A Great Deal
9
10

3. To what degree is the fatigue you are feeling now interfering with your ability to complete
your work or school activities?
None
1
2.

3.

4

5

6

7

8.

A Great Deal
9
10

4. To what degree is the fatigue you are feeling now interfering with your ability to socialize
with your friends?
None
1
2.

3.

4

5

6

7

8.

A Great Deal
9
10

5. To what degree is the fatigue you are feeling now interfering with your ability to engage in
sexual activity?
None

A Great Deal
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2.

3.

4

5
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6

7

8.

9

10

6. Overall, how much is the fatigue which you are now experiencing interfering with your ability
to engage in the kind of activities you enjoy doing?
None
1
2.

3.

4

5

6

7

8.

A Great Deal
9
10

7. How would you describe the degree of intensity or severity of the fatigue which you are
experiencing now?
Mild
1
2

3

4

5

6

7

8

9

Severe
10

8. To what degree would you describe the fatigue which you are experiencing now as being?
Pleasant
1
2

3

4

5

6

7

8

Unpleasant
9
10

9. To what degree would you describe the fatigue which you are experiencing now as being?
Agreeable
1

2

Disagreeable
3

4

5

6

7

8

9

10

10. 10. To what degree would you describe the fatigue which you are experiencing now as
being?
Protective
1
2

3

4

5

6

7

8

Destructive
9
10

11. To what degree would you describe the fatigue which you are experiencing now as being?
Positive
1
2

3

4

5

6

7

8

Negative
9
10

12. To what degree would you describe the fatigue which you are experiencing now as being:
Normal
1
2

3

4

5

6

7

8

Abnormal
9
10

13. To what degree are you now feeling:
Strong
1
2

3

4

5

6

7

8

9

Weak
10
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14. To what degree are you now feeling:
Awake
1
2

3

4

5

6

7

8

Sleepy
9

10

9

Listless
10

9

Tired
10

15. To what degree are you now feeling:
Lively
1
2

3

4

5

6

7

8

16. To what degree are you now feeling:
Refreshed
1
2

3

4

5

6

7

8

17. To what degree are you now feeling:
Energetic
1
2

3

4

5

6

8

Unenergetic
9
10

7

8

Impatient
9
10

7

8

A Great Deal
9
10

7

8

Depressed
9
10

7

18. To what degree are you now feeling:
Patient
1
2

3

4

5

6

19. To what degree are you now feeling:
Relaxed
1
2

3

4

5

6

20. To what degree are you now feeling:
Exhilarated
1
2
3

4

5

6

21. To what degree are you now feeling:
Able to Concentrate
1
2
3
4

5

6

22. To what degree are you now feeling:

7

Unable to Concentrate
8
9
10
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6

7

Unable to Remember
8
9
10

7

Unable to Think Clearly
8
9
10

23. To what degree are you now feeling:
Able to Think Clearly
1
2
3
4

5

6

24. Overall, what do you believe is most directly contributing to or causing your fatigue?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
25. Overall, the best thing you have found to relieve your fatigue is: _____________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
26. Is there anything else you would like to add that would describe your fatigue better to us?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
27. Are you experiencing any other symptoms right now? _____________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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